Having originally researched the activities of the potent hematopeotic stimulator of bone-marrow cells, granulocyte colony stimulating factor, Shigekazu Nagata is better known for his work on ...
allowing them to migrate into densely populated tissues. Here they are shown in human bone marrow (purple cells) in the company of many red blood cells.
Effect of Splenectomy on the Response to Platelet Transfusion in Three Patients with Aplastic Anemia
Improved hemoglobin and granulocyte values were noted, but the role of these medications in promoting remission of disease after seven months is uncertain. Cytogenetic studies of the bone marrow ...
New research shows that mutations in DNMT3A in blood stem cells of frequent blood donors may bolster the production of noncancerous cells.
“The study provides robust evidence for targeting residual disease in the bone and bone marrow, a common niche for chemoresistant cells in patients with primary refractory or relapsed disease.
Flow cytometric purification of GFP-expressing bone marrow cells. Twenty-four hours ... animal that had received stem-cell factor (SCF) and granulocyte colony stimulating factor for five ...
“The study provides robust evidence for targeting residual disease in the bone and bone marrow, a common niche for chemoresistant cells in patients with primary refractory or relapsed disease.” The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback